74 related articles for article (PubMed ID: 32606420)
1. The value of targeting recombination as a strategy against coronavirus diseases.
Santiago E; Caballero A
Heredity (Edinb); 2020 Oct; 125(4):169-172. PubMed ID: 32606420
[No Abstract] [Full Text] [Related]
2. Coronavirus puts drug repurposing on the fast track.
Harrison C
Nat Biotechnol; 2020 Apr; 38(4):379-381. PubMed ID: 32205870
[No Abstract] [Full Text] [Related]
3. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery.
Wright LR; Wright DL; Weller SK
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891537
[TBL] [Abstract][Full Text] [Related]
4. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
Islam MT; Sarkar C; El-Kersh DM; Jamaddar S; Uddin SJ; Shilpi JA; Mubarak MS
Phytother Res; 2020 Oct; 34(10):2471-2492. PubMed ID: 32248575
[TBL] [Abstract][Full Text] [Related]
5. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
6. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
7. Lack of small animal model hinders MERS coronavirus research.
Devitt E
Nat Med; 2013 Aug; 19(8):952. PubMed ID: 23921729
[No Abstract] [Full Text] [Related]
8. [Mechanisms of the formation of viral resistance to chemotherapeutic preparations].
Chizhov NP
Vopr Virusol; 1985; 30(3):266-79. PubMed ID: 3901520
[No Abstract] [Full Text] [Related]
9. Lithium for the 2019 novel coronavirus.
Gómez-Bernal G
Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
[No Abstract] [Full Text] [Related]
10. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
11. Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity.
Yang CW; Lee YZ; Hsu HY; Shih C; Chao YS; Chang HY; Lee SJ
Sci Rep; 2017 Jun; 7(1):4105. PubMed ID: 28642467
[TBL] [Abstract][Full Text] [Related]
12. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
Brown RE; Hunter RL
Ann Clin Lab Sci; 2020 Mar; 50(2):287-288. PubMed ID: 32366572
[No Abstract] [Full Text] [Related]
13. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
Wang H; Xue S; Yang H; Chen C
Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
[TBL] [Abstract][Full Text] [Related]
14. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Graphene-Silver Nanocomposites against Non-Enveloped and Enveloped Viruses.
Chen YN; Hsueh YH; Hsieh CT; Tzou DY; Chang PL
Int J Environ Res Public Health; 2016 Apr; 13(4):430. PubMed ID: 27104546
[TBL] [Abstract][Full Text] [Related]
16. Engineering Coronaviruses to Evaluate Emergence and Pathogenic Potential.
Lau SKP; Woo PCY
Trends Microbiol; 2016 Jun; 24(6):427-429. PubMed ID: 27095615
[TBL] [Abstract][Full Text] [Related]
17. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus.
Rossignol JF
J Infect Public Health; 2016; 9(3):227-30. PubMed ID: 27095301
[TBL] [Abstract][Full Text] [Related]
18. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.
Cinatl J; Morgenstern B; Bauer G; Chandra P; Rabenau H; Doerr HW
Lancet; 2003 Jun; 361(9374):2045-6. PubMed ID: 12814717
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharides inhibit avian infectious bronchitis virus infection by regulating viral replication.
Zhang P; Liu X; Liu H; Wang W; Liu X; Li X; Wu X
Microb Pathog; 2018 Jan; 114():124-128. PubMed ID: 29170045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
